<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36810758</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0028-3843</ISSN><JournalIssue CitedMedium="Print"><Volume>57</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Neurologia i neurochirurgia polska</Title><ISOAbbreviation>Neurol Neurochir Pol</ISOAbbreviation></Journal><ArticleTitle>Course of fatigue among patients previously hospitalised due to COVID-19.</ArticleTitle><Pagination><StartPage>101</StartPage><EndPage>110</EndPage><MedlinePgn>101-110</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5603/PJNNS.a2023.0015</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Discrepancies exist regarding the clinical course and prognostic factors for post-COVID fatigue. Therefore, our aim was to assess the timely course of fatigue and its possible predictors in patients previously hospitalised due to SARS-CoV-2 infection.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Patients and employees of the University Hospital in Krakow were assessed with the use of a validated neuropsychological questionnaire. Included were participants aged 18 or more, previously hospitalised due to COVID-19, who completed questionnaires only once &gt; 3 months after the onset of infection. Individuals were retrospectively asked about the presence of eight symptoms of chronic fatigue syndrome at four timepoints: before COVID-19, within 0-4 weeks, 4-12 weeks, and &gt; 12 weeks post-infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We enrolled 204 patients [40.2% women, median age 58 (46-66) years] evaluated after a median of 187 (156-220) days from the first positive nasal swab test for SARS-CoV-2. The most common comorbidities were hypertension (44.61%), obesity (36.27%), smoking (28.43%), and hypercholesterolemia (21.08%); none of the patients required mechanical ventilation during hospitalisation. Before COVID-19, 43.62% of patients reported at least one symptom of chronic fatigue. Within 4, 4-12, and &gt; 12 weeks after COVID-19, the prevalence of chronic fatigue was 76.96%, 75.49%, and 66.17%, respectively (all p &lt; 0.001). The frequency of chronic fatigue symptoms decreased within &gt; 12 weeks following the onset of infection but did not return to baseline values, except for self-reported lymph node enlargement. In a multivariable linear regression model, the number of fatigue symptoms was predicted by female sex [&#x3b2; 0.25 (0.12; 0.39), p &lt; 0.001 and 0.26 (0.13; 0.39), p &lt; 0.001 for weeks 0-12 and &gt; 12, respectively], and age [for &lt; 4 weeks, &#x3b2; -0.12 (-0.28; -0.01), p = 0.029].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most patients previously hospitalised due to COVID-19 suffer from fatigue &gt; 12 weeks after infection onset. The presence of fatigue is predicted by female sex and - only for the acute phase - age.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mazurkiewicz</LastName><ForeName>Iwona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospital in Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatys-Bogacka</LastName><ForeName>&#x17b;aneta</ForeName><Initials>&#x17b;</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospital in Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#x142;owik</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Periodontology, Preventive Dentistry and Oral Medicine, Institute of Dentistry, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zdanecka</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Department of Gynaecological Endocrinology and Gynaecology, University Hospital in Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siwiec-Ko&#x17a;lik</LastName><ForeName>And&#x17c;elika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology and Immunology Clinical Department, University Hospital in Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#x142;owik</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospital in Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drabik</LastName><ForeName>Leszek</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>John Paul II Hospital, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wnuk</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jagiellonian University Medical College, Krakow, Poland. marcin.wnuk@uj.edu.pl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospital in Krakow, Poland. marcin.wnuk@uj.edu.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Neurol Neurochir Pol</MedlineTA><NlmUniqueID>0101265</NlmUniqueID><ISSNLinking>0028-3843</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">middle aged</Keyword><Keyword MajorTopicYN="N">neurological manifestations</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>14</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36810758</ArticleId><ArticleId IdType="doi">10.5603/PJNNS.a2023.0015</ArticleId><ArticleId IdType="pii">VM/OJS/J/94078</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>